578 related articles for article (PubMed ID: 15085135)
1. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T
Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
Zawawi MS; Dharmapatni AA; Cantley MD; McHugh KP; Haynes DR; Crotti TN
Biochem Biophys Res Commun; 2012 Oct; 427(2):404-9. PubMed ID: 23000414
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insight into osteoclast differentiation in osteoimmunology.
Takayanagi H
J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
[TBL] [Abstract][Full Text] [Related]
4. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
[TBL] [Abstract][Full Text] [Related]
5. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
6. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.
Xu J; Tan JW; Huang L; Gao XH; Laird R; Liu D; Wysocki S; Zheng MH
J Bone Miner Res; 2000 Nov; 15(11):2178-86. PubMed ID: 11092398
[TBL] [Abstract][Full Text] [Related]
7. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis.
Kim HS; Kim DK; Kim AR; Mun SH; Lee SK; Kim JH; Kim YM; Choi WS
Cell Signal; 2012 Jun; 24(6):1306-14. PubMed ID: 22387224
[TBL] [Abstract][Full Text] [Related]
8. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
Takayanagi H; Kim S; Matsuo K; Suzuki H; Suzuki T; Sato K; Yokochi T; Oda H; Nakamura K; Ida N; Wagner EF; Taniguchi T
Nature; 2002 Apr; 416(6882):744-9. PubMed ID: 11961557
[TBL] [Abstract][Full Text] [Related]
9. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
10. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
11. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast signalling pathways.
Blair HC; Robinson LJ; Zaidi M
Biochem Biophys Res Commun; 2005 Mar; 328(3):728-38. PubMed ID: 15694407
[TBL] [Abstract][Full Text] [Related]
13. The role of NFAT in osteoclast formation.
Takayanagi H
Ann N Y Acad Sci; 2007 Nov; 1116():227-37. PubMed ID: 18083930
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
15. A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-beta production.
Shin HH; Lee EA; Kim SJ; Kwon BS; Choi HS
FEBS Lett; 2006 Mar; 580(6):1601-6. PubMed ID: 16480981
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
17. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
Wattel A; Kamel S; Prouillet C; Petit JP; Lorget F; Offord E; Brazier M
J Cell Biochem; 2004 May; 92(2):285-95. PubMed ID: 15108355
[TBL] [Abstract][Full Text] [Related]
18. RANKing intracellular signaling in osteoclasts.
Feng X
IUBMB Life; 2005 Jun; 57(6):389-95. PubMed ID: 16012047
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
Humphrey MB; Nakamura MC
Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
[TBL] [Abstract][Full Text] [Related]
20. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
